News

Novo Nordisk confirmed Wegovy's entry into the New Zealand market and said in a statement that it is in discussions with the ...
With the recent approval in China of Innovent Biologics' (OTCPK:IVBIY) mazdutide as the first-ever dual GLP-1/glucagon ...